Nexgard spectra vs bravecto full#
Nexgard spectra vs bravecto plus#

Use with caution in dogs with a history of seizures or neurologic disorders. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS has not been established in breeding, pregnant, and lactating cats.Īll BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for cats are for topical use only. BRAVECTO Chews and Topical Solution for dogs is not effective against the lone star tick beyond 8 weeks of dosing. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.īRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Use with caution in cats that are heartworm positive. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age.

Nexgard spectra vs bravecto plus#

BRAVECTO PLUS Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. americanum in puppies less than 6 months of age. BRAVECTO 1-MONTH is not effective against A. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. Plus, they're brought to you by Boehringer Ingelheim, a company proud to be passionate about animal health.BRAVECTO 1-MONTH Chews: indicated for dogs 8 weeks of age and older. In a tasty, bite-sized chewable, NexGard brand kills adult fleas before they lay eggs, and kills several dangerous ticks! With a variety of sizes, you can choose the perfect NexGard chewable that's right for your furry family and set the worry aside. From the makers of FRONTLINE Plus, the # 1 choice of veterinarians, now comes the first flea and tick killer in a beef-flavored chew. NexGard is the flea and tick protection recommended by vets. ©2022 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All other trademarks are property of their respective owners. HEARTGARD® and the Dog & Hand logo® are registered trademarks of Boehringer Ingelheim Health USA Inc. NexGard® is a registered trademark and FRONTLINE VET LABS™ is a trademark of the Boehringer Ingelheim Group.

Nexgard spectra vs bravecto full#

For more information, click here for full prescribing information or visit. Following the use of HEARTGARD Plus, digestive and neurological side effects have rarely been reported. All dogs should be tested for heartworm infection before starting a preventive program. HEARTGARD® Plus (ivermectin/pyrantel) is well tolerated. For more information, contact your veterinarian, visit or click here for full prescribing information. The safe use of NexGard in pregnant, breeding, or lactating dogs has not been evaluated.

The most frequently reported adverse reactions include vomiting, itching, lethargy, diarrhea, and lack of appetite. NexGard® (afoxolaner) is for use in dogs only.